MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-20-0031044
Nitika Pharmaceutical Specialities Private Limited - chemicals and materials in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹80.91 Cr
▲ 35% YoY
Net profit · FY 2024
₹5.71 Cr
Net margin 7.1%
EBITDA · FY 2024
₹12.45 Cr
EBITDA margin 15.4%
Authorised capital
₹9.5 Cr
Registered with MCA
Paid-up capital
₹3.14 Cr
Issued & subscribed
Open charges
₹180.53 Cr
Satisfied ₹20.77 Cr
Company age
15 yrs
Est. 2011
Employees · EPFO
122
Provident fund records
About Nitika Pharmaceutical Specialities Private Limited
Data last updated:
Nitika Pharmaceutical Specialities Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 12 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24230MH2011PTC214662. Its GSTIN is 27AADCN7442F1ZG (Maharashtra).
The company has an authorised share capital of ₹9.5 Cr and a paid-up capital of ₹3.14 Cr. It was formerly known as Nitika Pharma Specialities Private Limited. It is led by directors including Ravleen Singh Khurana and Manojkumar Badrinarayan Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Nagpur, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹80.91 Cr, a growth of 35% compared to the previous year. For the same year it recorded a net profit of ₹5.71 Cr (net margin 7.1%) and EBITDA of ₹12.45 Cr (EBITDA margin 15.4%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 20% over five years.
The company has about 122 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Nitika Pharmaceuticals. As per MCA filings, the company has open charges of ₹180.53 Cr and satisfied charges of ₹20.77 Cr on record. Court records list 14 cases involving the company, including 7 filed by the company and 7 filed against it; 4 cases are pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹2.13 Cr; the latest was in March 2019. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Oscar Remedies Pvt Ltd with revenue of ₹82.04 Cr. The company has 4 MSME Form 1 returns on record between 2019 and 2022, listing 28 overdue payments to 20 micro and small suppliers.
Nitika Pharmaceutical Specialities Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0031044). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nitikapharma.com.
Company details
CIN U24230MH2011PTC214662
Registration Number 214662
Incorporation Date 12 March 2011
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-20-0031044
Key People
Ravleen Singh Khurana Director Manojkumar Badrinarayan Agrawal Director Parvinder Singh Director Recognitions & Rankings of Nitika Pharmaceutical Specialities
Contact details
Nitika Pharmaceutical Specialities Private Limited's registered office is in Nagpur, Maharashtra. Its website is nitikapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFortune Ritz F. No. 101 Pl. 240/A, Near Raja Rani Square Civil Lines, Nagpur, Maharashtra, India – 440001
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Nitika Pharmaceutical Specialities Private Limited, buy the company report.
Comprehensive company report
Nitika Pharmaceutical Specialities Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Nitika Pharmaceutical Specialities operates one associated brand: Nitika Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of pharmaceutical excipients, antacid actives, and mineral salts in India. | nitikapharma.com |
Business activity
The main business activity of Nitika Pharmaceutical Specialities is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Nitika Pharmaceutical Specialities Private Limited, buy the company report.
Financials of Nitika Pharmaceutical Specialities Private Limited
FY 2024 filings availableNitika Pharmaceutical Specialities Private Limited reported revenue of ₹80.91 Cr (up 35% YoY) for FY 2024.
Revenue · FY 2024
₹80.91 Cr ▲ 35%
Net profit · FY 2024
₹5.71 Cr margin 7.1%
EBITDA · FY 2024
₹12.45 Cr margin 15.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 35%
3 years · compounded
▲ 23%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▲ 83%
3 years · compounded
▲ 33%
5 years · compounded
▲ 50%
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 35% growth in the latest year. EBITDA rose 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.45 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.71 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.4% | ||||
| Net Profit Margin | 7.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nitika Pharmaceutical Specialities Private Limited, buy the company report.
Board of directors of Nitika Pharmaceutical Specialities Private Limited
Nitika Pharmaceutical Specialities has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravleen Singh Khurana | Director | 12 Mar 2011 | 15 Years 7 Months | Current |
| Manojkumar Badrinarayan Agrawal Also directs: Infill Life Sciences LLP | Director | 10 Jul 2018 | 8 Years 3 Months | Current |
| Parvinder Singh | Director | 11 Jul 2019 | 7 Years 3 Months | Current |
Peer comparison
Nitika Pharmaceutical Specialities Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Oscar Remedies Pvt Ltd | ₹82.04 Cr (FY 2025) | 15.0% | Haryana, India | |||
| Sun Life Sciences Private Limited | ₹81.57 Cr (FY 2024) | 17.0% | Bangalore, Karnataka, India | |||
| Indian Drugs and Pharmaceuticals Limited | ₹81.46 Cr (FY 2015) | 7.0% | Gurgaon, Haryana, India | |||
| Optimus Pharma Private Limited | ₹81.17 Cr (FY 2025) | -40.0% | Hyderabad, Telangana, India | |||
| Nitika Pharmaceutical Specialities Private Limitedthis company | ₹80.91 Cr (FY 2024) | ₹5.71 Cr | 7.1% | 35.0% | 122 | Nagpur, Maharashtra, India |
| Endoc Lifecare Private Limited | ₹80.74 Cr (FY 2025) | -8.0% | Rajkot, Gujarat, India | |||
| Nikvin Healthcare (India) Private Limited | ₹80.65 Cr (FY 2025) | 42.0% | New Delhi, Delhi, India | |||
| Adroit Pharmaceuticals Private Limited | ₹80.51 Cr (FY 2024) | 2.0% | Mumbai, Maharashtra, India | |||
| Salud Care (India) Limited | ₹80.41 Cr (FY 2025) | 16.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Nitika Pharmaceutical Specialities Private Limited, buy the company report.
Auditor
Nitika Pharmaceutical Specialities Private Limited is audited by BHASIN DATAR ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHASIN DATAR ASSOCIATES | FY 2023 | 115725W |
Shareholding
The shareholding of Nitika Pharmaceutical Specialities Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nitika Pharmaceutical Specialities Private Limited, buy the company report.
Charges & borrowings
Open charges
₹180.53 Cr
Satisfied charges
₹20.77 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Jul 2025 | 101130521 | Bank of India | ₹3 Cr | Open | |
| 30 May 2025 | 101107432 | Others | ₹100 Cr | Open | |
| 12 Dec 2023 | 100827444 | Bank of India | ₹35 Cr | Open | |
| 22 Mar 2022 | 100589266 | Axis Bank Limited | ₹42.19 Cr | Open | |
| 27 Nov 2020 | 100398649 | Hdfc Bank Limited | ₹34 Lakh | Open |
To see the full charge records of Nitika Pharmaceutical Specialities Private Limited, buy the company report.
Total charge records: 10 View all charges
Deals & funding
Nitika Pharmaceutical Specialities Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹2.13 Cr; the latest was in March 2019.
Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹2.13 Cr
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2012 | Funding round | ₹2.13 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Nitika Pharmaceutical Specialities Private Limited has 14 court cases on record: 7 filed by Nitika Pharmaceutical Specialities, 7 filed against it. 4 cases are pending and 10 are disposed.
Total cases
14
Filed by the company
7
Filed against the company
7
Pending
4
Disposed
10
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 7 | 3 |
| High courts | 4 | 0 | 1 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Court case (Sum.Civ.Suit) | Filed against the company by Asmaco Industries Ltd. and 4 others | Pending |
| District court, South East, Delhi | Civil suit | Filed against the company by Globus Transitos Pvt. Ltd. | Disposed |
| District court, Nagpur, Maharashtra | Civil suit | Filed by the company against an individual | Pending |
| District court, Nagpur, Maharashtra | Civil suit | Filed by the company against an individual | Pending |
| High Court, MAHARASHTRA | Court case (CEL) | Filed by the company against The Commissioner of Central Tax and GST, Nagpur | Pending |
To see the full case history of Nitika Pharmaceutical Specialities Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Nitika Pharmaceutical Specialities Private Limited has 4 MSME Form 1 returns on record between 2019 and 2022, listing 28 overdue payments to 20 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 20)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| Modern Living Solutions Private Limited | |||
| Appario Retail Private Limited | |||
| Shivalik Paper and Packaging |
To see the full MSME payment records of Nitika Pharmaceutical Specialities Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Nitika Pharmaceutical Specialities Private Limited has a workforce of 122 employees on its EPFO records as of Dec 14, 2024, across 1 active EPFO establishment.
Employee count
122
Active EPFO establishments
1
Employee growth
31.18%
GST
Nitika Pharmaceutical Specialities has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCN7442F1ZG | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nitika Pharmaceutical Specialities Private Limited, buy the company report.
Recent activity
Nitika Pharmaceutical Specialities Private Limited has 8 board changes on record since 2011: 3 appointments and 5 cessations. The latest: Manishkumar Mansukhbhai Kagathara ceased to be Director on 31 Mar 2022.
Charges
A charge with Bank Of India amounted to Rs. 3.00 Cr with Charge ID 101130521 was registered on 16 Jul 2025.
Charges
A charge with Others amounted to Rs. 100.00 Cr with Charge ID 101107432 was registered on 30 May 2025.
Charges
A charge registered on 20 May 2023 via Charge ID 100729002 with Bank Of India was fully satisfied on 07 May 2025.
AGM
Nitika Pharmaceutical Specialities Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Nitika Pharmaceutical Specialities Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Nagpur.
Charges
A charge registered on 28 Mar 2012 via Charge ID 10350851 with Bank Of India was fully satisfied on 15 Mar 2024.
Charges
A charge with Bank Of India of Rs. 35.00 Cr registered on 12 Dec 2023 with Charge ID 100827444 was modified on 13 Dec 2023.
Charges
A charge with Axis Bank Limited of Rs. 42.19 Cr registered on 22 Mar 2022 with Charge ID 100589266 was modified on 13 Dec 2023.
Charges
A charge with Bank Of India amounted to Rs. 35.00 Cr with Charge ID 100827444 was registered on 12 Dec 2023.
Charges
A charge with Bank Of India amounted to Rs. 3.00 Cr with Charge ID 100729002 was registered on 20 May 2023.
Charges
A charge with Bank Of India of Rs. 16.37 Cr registered on 28 Mar 2012 with Charge ID 10350851 was modified on 30 Aug 2022.
Ceased
Manishkumar Mansukhbhai Kagathara ceased to be Director.
17 earlier events are in the company report.
Frequently asked questions
Nitika Pharmaceutical Specialities is an active private limited company based in Nagpur, Maharashtra, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 12 March 2011 (15+ years old) and is registered under CIN U24230MH2011PTC214662.
Nitika Pharmaceutical Specialities has 3 current directors:
- Ravleen Singh Khurana - Director
- Manojkumar Badrinarayan Agrawal - Director
- Parvinder Singh - Director
The latest financial statements of Nitika Pharmaceutical Specialities on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Nitika Pharmaceutical Specialities is 27AADCN7442F1ZG, registered in Maharashtra.
The CIN (Corporate Identification Number) of Nitika Pharmaceutical Specialities is U24230MH2011PTC214662. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nitika Pharmaceutical Specialities has 14 court cases on record: 7 filed by the company and 7 filed against it. 4 are pending. Most are in the district courts.
Nitika Pharmaceutical Specialities was incorporated on 12 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Nagpur.
Nitika Pharmaceutical Specialities has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹2.13 Cr; the latest was in March 2019.
The peers of Nitika Pharmaceutical Specialities by revenue are Oscar Remedies Pvt Ltd, Sun Life Sciences Private Limited, Indian Drugs and Pharmaceuticals Limited, Optimus Pharma Private Limited, Endoc Lifecare Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Manishkumar Mansukhbhai Kagathara ceased to be Director on 31 Mar 2022. Parvinder Singh ceased to be Additional Director on 30 Sep 2019. Parvinder Singh was appointed as Director on 11 Jul 2019. Nitika Pharmaceutical Specialities has 8 board changes on record in total.
Yes, Nitika Pharmaceutical Specialities is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-20-0031044).
Nitika Pharmaceutical Specialities has 4 MSME Form 1 returns on record between 2019 and 2022, listing 28 overdue payments to 20 micro and small suppliers. The latest return was filed on 08 Dec 2022.